STOCK TITAN
  1. Home
  2. ONCWF

Oncolytics Bio Stock Price, News & Analysis

ONCWF OTC

Company Description

Oncolytics Bio (OTC: ONCWF) is a publicly traded biotechnology company in the Health Technology sector.

ONCWF stock has declined 89.0% over the past year.

This page provides a comprehensive overview of ONCWF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-89.02%
Performance 1 year
$0.0
Market Cap
0.0
Shares outstanding

Oncolytics Bio (ONCWF) stock. Over the past 12 months, the stock has lost 89.0%.

Latest News

View All
-23.81%

Oncolytics Biotech® and SOLTI Present New Clinical Biomarker Data Demonstrating Pelareorep's Potential to Improve the Prognosis of Breast Cancer Patients at the ESMO Breast Cancer Meeting

-1.56%

Oncolytics Biotech® Announces Positive Long-Term Survival Data from Phase 1b Glioblastoma Multiforme Trial at the AACR Annual Meeting

clinical trial
—

Oncolytics Biotech®Partner Adlai Nortye Doses First Patient in Chinese Bridging Trial Evaluating Pelareorep-Paclitaxel Combination Treatment in Breast Cancer

—

Oncolytics Biotech® Reports 2021 Second Quarter Development Highlights and Financial Results

earnings
—

Oncolytics Biotech® to Host Conference Call to Discuss Second Quarter Financial Results and Operational Highlights

conferences earnings
—

Oncolytics Biotech® Announces Clinical and Biomarker Data Demonstrating Clinical Proof-of-Concept for Pelareorep-Checkpoint Inhibitor Combination in Pancreatic Cancer

Oncolytics Bio has 8 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 2 with negative movement. Key topics include clinical trial, earnings, conferences, management. View all ONCWF news →

SEC Filings

View All

No SEC filings available for ONCWF.

Financial Highlights

View Full Financials
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

ONCWF Company Profile & Sector Positioning

Oncolytics Bio (ONCWF) operates in the Biotechnology industry within the broader Health Technology sector and is listed on the OTC.